Cancer Biology & Therapy,
Год журнала:
2025,
Номер
26(1)
Опубликована: Фев. 4, 2025
Acute
lymphocytic
leukemia
(ALL)
is
the
most
common
in
children,
with
T-cell
subtype
(T-ALL)
accounting
for
15%
of
those
cases.
Despite
advancements
treatment
T-ALL,
patients
still
face
a
dismal
prognosis
following
their
first
relapse.
Relapse
can
be
attributed
to
inability
chemotherapy
agents
eradicate
stem
cells
(LSC),
which
possess
self-renewal
capabilities
and
are
responsible
long-term
maintenance
disease.
Mitochondria
have
been
recognized
as
therapeutic
vulnerability
cancer
cells,
including
LSCs.
Mitocans
shown
promise
T-ALL
both
vitro
vivo,
some
currently
early-phase
clinical
trials.
However,
due
challenges
studying
LSCs
our
understanding
how
mitochondrial
function
influences
remains
limited.
This
review
highlights
emerging
literature
on
targeting
mitochondria
diverse
models,
emphasizing
specific
vulnerabilities
linked
LSC
potential
significantly
improve
treatment.
ACS Biomaterials Science & Engineering,
Год журнала:
2022,
Номер
8(2), С. 348 - 359
Опубликована: Янв. 3, 2022
Mitochondria
play
an
essential
role
in
cellular
metabolism
and
generate
energy
cells.
To
support
these
functions,
several
proteins
are
encoded
the
mitochondrial
DNA
(mtDNA).
The
mutation
of
mtDNA
causes
dysfunction
ultimately
results
a
variety
inherited
diseases.
date,
gene
delivery
systems
targeting
mitochondria
have
been
developed
to
ameliorate
mutations.
However,
applications
strategies
therapy
still
being
explored
optimized.
Thus,
from
this
perspective,
we
herein
highlight
recent
mitochondria-targeting
for
discuss
future
directions
effective
mitochondria-targeted
delivery.
Cancers,
Год журнала:
2023,
Номер
15(7), С. 1936 - 1936
Опубликована: Март 23, 2023
Breast
cancer
is
the
most
frequently
diagnosed
malignancy
worldwide
and
leading
cause
of
mortality
in
women.
Despite
recent
development
new
therapeutics
including
targeted
therapies
immunotherapy,
triple-negative
breast
remains
an
aggressive
form
cancer,
thus
improved
treatments
are
needed.
In
decades,
it
has
become
increasingly
clear
that
cancers
harbor
metabolic
plasticity
controlled
by
mitochondria.
A
myriad
studies
provide
evidence
mitochondria
essential
to
progression.
Mitochondria
widely
reprogrammed
enhance
energy
production
biosynthesis
macromolecules
required
for
tumor
growth.
this
review,
we
will
discuss
current
understanding
mitochondrial
roles
elucidate
why
a
rational
therapeutic
target.
We
then
outline
status
use
mitochondria-targeting
drugs
cancers,
highlight
ClpP
agonists
as
emerging
with
unique
mechanism
action.
also
illustrate
possible
drug
combination
strategies
challenges
future
clinic.
Biomaterials and Biosystems,
Год журнала:
2021,
Номер
3, С. 100023 - 100023
Опубликована: Авг. 13, 2021
The
early
understanding
of
mitochondria
posited
that
they
were
'innocent
organelles'
solely
devoted
to
energy
production
and
utilisation.
Intriguingly,
recent
findings
have
outlined
in
detail
the
'modern-day'
view
are
an
important
but
underappreciated
drug
target.
Mitochondria
been
implicated
pathophysiology
many
human
diseases,
ranging
from
neurodegenerative
disorders
cardiovascular
diseases
infections
cancer.
It
is
now
clear
normal
mitochondrial
function
involves
building
blocks
a
cell
generate
lipids,
proteins
nucleic
acids
thereby
facilitating
growth.
On
other
hand,
dysfunction
reprograms
crucial
cellular
functions
into
pathological
pathways,
considered
as
integral
hallmark
Therefore,
strategies
target
can
provide
wealth
new
therapeutic
approaches
fight
against
cancer,
by
overcoming
number
problems
associated
with
conventional
pharmaceutical
drugs,
including
low
solubility,
poor
bioavailability
non-selective
biodistribution.
combination
nanoparticles
'classical'
chemotherapeutic
drugs
create
biocompatible,
multifunctional
mitochondria-targeted
nanoplatforms
has
recently
studied.
This
approach
rapidly
expanding
for
targeted
delivery
systems,
hybrid
nanostructures
be
activated
light
(photodynamic
and/or
photothermal
therapy).
selective
elegant
shortcut
more
selective,
targeted,
safer
cancer
treatment.
We
propose
use
termed
"mitoNANO".
present
minireview
sheds
on
design
application
mitoNANO
advanced
therapeutics,
may
overcome
resistance
show
fewer
side
effects.
Molecules,
Год журнала:
2021,
Номер
27(1), С. 148 - 148
Опубликована: Дек. 27, 2021
Reactive
oxygen
species
(ROS)
are
rapidly
eliminated
and
reproduced
in
organisms,
they
always
play
important
roles
various
biological
functions
abnormal
pathological
processes.
Evaluated
ROS
have
frequently
been
observed
cancers
to
activate
multiple
pro-tumorigenic
signaling
pathways
induce
the
survival
proliferation
of
cancer
cells.
Hydrogen
peroxide
(H2O2)
superoxide
anion
(O2•−)
most
redox
agents
cells,
homeostasis
which
is
maintained
by
dozens
growth
factors,
cytokines,
antioxidant
enzymes.
Therefore,
enzymes
tend
higher
activity
levels
maintain
Effective
intervention
cells
chelating
or
metal
complexes
has
already
developed
into
an
anti-cancer
strategy.
We
can
inhibit
using
chelators
complexes;
on
other
hand,
we
also
use
directly
regulate
level
via
mitochondria.
In
this
review,
with
regulation
capacity
applications
collectively
comprehensively
analyzed,
beneficial
for
development
next
generation
inorganic
drugs
based
regulation.
expect
that
review
will
provide
a
new
perspective
develop
novel
reagents
killing
and,
further,
as
candidates
clinical
drugs.
ACS Nano,
Год журнала:
2022,
Номер
16(11), С. 17497 - 17551
Опубликована: Ноя. 2, 2022
Despite
their
clinical
success
in
drug
delivery
applications,
the
potential
of
theranostic
nanomedicines
is
hampered
by
mechanistic
uncertainty
and
a
lack
science-informed
regulatory
guidance.
Both
therapeutic
efficacy
toxicity
nanoformulations
are
tightly
controlled
complex
interplay
nanoparticle's
physicochemical
properties
individual
patient/tumor
biology;
however,
it
can
be
difficult
to
correlate
such
information
with
observed
outcomes.
Additionally,
as
nanomedicine
research
attempts
gradually
move
away
from
large-scale
animal
testing,
need
for
computer-assisted
solutions
evaluation
will
increase.
Such
models
depend
on
clear
understanding
structure–activity
relationships.
This
review
provides
comprehensive
overview
field
cancer
knowledge
framework
foundational
interaction
maps
that
facilitate
future
research,
assessments,
regulation.
By
forming
three
complementary
profiling
nanobio
interactions
pathways
at
different
levels
biological
complexity,
picture
journey
through
body
adverse
consequences
each
presented.
Inorganic Chemistry,
Год журнала:
2023,
Номер
62(8), С. 3395 - 3408
Опубликована: Фев. 10, 2023
Half-sandwich
iridium(III)
complexes
show
potential
value
in
the
anticancer
field.
However,
with
favorable
luminescence
performance
are
rare,
which
limits
further
investigation
of
mechanism.
In
this
paper,
10
triphenylamine-modified
fluorescent
half-sandwich
pyridine
{[(η5-Cpx)Ir(L)Cl2]}
(Ir1-Ir10)
were
prepared
and
showed
antiproliferative
activity,
effectively
inhibiting
migration
A549
cells.
Ir6,
showing
best
activity
among
these
complexes,
exhibited
excellent
fluorescence
(absolute
quantum
yield
15.17%)
solution.
Laser
confocal
detection
that
Ir6
followed
an
energy-dependent
cellular
uptake
mechanism,
specifically
accumulating
mitochondria
(Pearson
co-localization
coefficient
0.95).
A
Western
blot
assay
confirmed
existence
a
mitochondrial
apoptotic
channel.
Additionally,
could
arrest
cell
cycle
at
G2/M
phase,
catalyze
NADH
oxidation,
reduce
membrane
potential,
induce
increase
level
intracellular
reactive
oxygen
species,
exhibit
mechanism
oxidation.
An
vivo
antitumor
can
inhibit
tumor
growth
is
safer
than
cisplatin.
Free Radical Biology and Medicine,
Год журнала:
2024,
Номер
220, С. 28 - 42
Опубликована: Апрель 27, 2024
Cancer
of
the
head
and
neck
encompasses
a
wide
range
cancers,
including
oral
oropharyngeal
cancers.
Oral
cancer
is
often
diagnosed
at
advanced
stages
has
dismal
prognosis.
Piscidin-1,
marine
antimicrobial
peptide
(AMP)
containing
approximately
22
amino
acids,
also
exhibits
significant
anticancer
properties.
We
investigated
possible
anti-oral
effects
piscidin-1
clarified
mechanisms
underlying
these
effects.
treated
squamous
cell
carcinoma
lines
OC2
SCC4
with
Piscidin-1.
Cell
viability
expression
different
hallmark
apoptotic
molecules,
reactive
oxygen
species
(ROS),
were
tested
using
appropriate
MTT
assay,
flow
cytometry
western
blotting
assays,
human
umbilical
vein
endothelial
(HUVEC)
wound
healing,
migration,
tube
formation
(angiogenesis)
assays.
Piscidin-1
increases
cleaved
caspase
3
levels
to
induce
apoptosis.
ROS
intensifies
oxidative
stress
in
endoplasmic
reticulum
mitochondria,
causing
mitochondrial
dysfunction.
Additionally,
it
decreases
consumption
rates
activity
complexes
I–V.
As
expected,
antioxidants
MitoTEMPOL
N-acetylcysteine
reduce
Piscidin-1–induced
generation
intracellular
calcium
accumulation.
inhibits
matrix
metalloproteinase
(MMP)-2/-9
HUVECs,
affecting
migration
angiogenesis.
demonstrated
that
can
promote
apoptosis
via
both
intrinsic
extrinsic
pathways
findings
indicate
anti-proliferative
anti-angiogenic
properties
treatment.
Our
study
on
thus
provides
basis
for
future
translational
drug
research
new
theoretical
approach
clinical
research.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(2), С. 784 - 784
Опубликована: Янв. 17, 2025
Although
pancreatic
cancer
presents
with
one
of
the
most
unfavorable
prognoses,
its
treatment
options
are
very
limited.
Mitochondria-targeting
moieties,
considered
a
new
and
prominent
modality,
expected
to
demonstrate
synergistic
anticancer
effects
due
their
distinct
mechanism
compared
conventional
chemotherapeutic
approaches.
This
study
evaluated
therapeutic
potential
mitochondria-accumulating
self-assembly
peptides,
referred
as
Mito-FFs,
utilizing
both
in
vitro
vivo
models.
Cellular
viability
assays
revealed
concentration-dependent
decrease
survival
MIA-PACA2
cells
upon
exposure
Mito-FF
(p
<
0.05).
Subsequent
treatments
prompted
use
several
molecular
analyses,
including
Real-time
PCR,
Western
blot
analysis,
MitoSOX
staining,
which
collectively
indicated
an
upsurge
apoptosis,
concurrent
reduction
antioxidant
enzyme
expression,
elevation
mitochondrial
ROS
levels
In
murine
xenograft
model
cancer,
intravenous
administration
yielded
notable
tumor
volume.
Moreover,
it
upregulated
expression
pro-apoptotic
markers,
such
cleaved
PARP
c-caspase
3,
while
concurrently
downregulating
anti-apoptotic
marker,
MCL-1,
evidenced
by
analysis
immunohistochemical
staining
It
also
resulted
reduced
enzymes
like
HO-1,
catalase,
SOD2
within
excised
tissues,
confirmed
using
Cumulatively,
findings
underscore
significant
efficacy
against
cells,
predominantly
mediated
through
induction
suppression
enhancement
microenvironment.
ACS Applied Materials & Interfaces,
Год журнала:
2025,
Номер
17(9), С. 13660 - 13675
Опубликована: Фев. 21, 2025
Photoactive
complexes
of
first-row
transition
metals
with
emission
properties
offer
a
dual
approach
to
cancer
treatment,
enabling
precise
optical
tumor
detection
and
subsequent
eradication
using
light.
We
report
photostable
photoactive
mixed-ligand
Mn(II)
complex,
Mn4,
featuring
naturally
occurring
curcumin
ligand
dipyridophenazine
base.
Mn4
demonstrates
significant
visible
red
light-triggered
phototoxicity
against
cells
imaging
capability
in
vivo.
The
complex
exhibits
an
absorption
band
the
region,
extending
its
tail
into
shows
excellent
dark
photostability
solution.
induces
HeLa
(cervical),
A549
(lung),
MCF-7
(breast)
(IC50
≈
1.0
μM),
as
well
3D
multicellular
spheroids,
under
low-energy
(400-700
nm)
red-light
(660
nm).
This
effect
is
mediated
by
cytotoxic
singlet
oxygen
proceeds
via
apoptotic
mechanism.
Importantly,
displays
significantly
lower
toxicity
toward
normal
HPL1D
lung
HEK-293
kidney
similar
conditions.
Cellular
uptake
studies
reveal
selective
accumulation
cells,
mitochondrial
localization,
negligible
BEAS-2B
cells.
Furthermore,
demonstrated
Mn4's
4T1
breast
tumor-bearing
vivo
mouse
model.
In
efficacy
orthotopic
model
show
that
reduces
volume
weight
dose-dependent
manner
blue
laser
(450
irradiation,
highlighting
potential
effective
photodynamic
therapy
(PDT)
agent.
Toxicological
confirm
does
not
induce
abnormal
biochemical
or
hematological
parameters
healthy
mice.
To
our
knowledge,
this
first
example
metal
for
combined
PDT
noninvasive
imaging,
paving
way
nonmacrocyclic
Mn-based
phototheranostics.